πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7288369

Replication competent hepatitis C virus and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7288646

USPA2 nucleic acid of Moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7285556

Thienopyrimidine-based inhibitors of the src family

The Board of Regents of the University of Texas System Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7271148

Inhibition of cellular proteases

The Board of Regents of the University of Texas System Β· Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7271161

Platinum complexes as antitumor agents in combination with biochemical modulation

The Board of Regents of the University of Texas System Β· Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7261875

Dendritic poly (amino acid) carriers and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7256047

Measurement of gluconeogenesis and intermediary metabolism using stable isotopes

The Board of Regents of the University of Texas System Β· Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7252989

Adenovirus supervector system

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7247316

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7247303

Selected antibody CDRs for binding to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244617

Diminishing viral gene expression by promoter replacement

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244760

Methods for preparation and use of psorospermin analogs

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244450

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7238366

Submicron liposome suspensions obtained from preliposome lyophilizates

The Board of Regents of the University of Texas System Β· Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7229604

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific dise

The Board of Regents of the University of Texas System Β· Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223388

Modified reoviral therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223787

Prenylation inhibitors reduce host cell permissiveness to viral replication

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223380

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific dise

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7220726

Antifungal pimaricin compositions and therapeutic methods employing same

The Board of Regents of the University of Texas System Β· Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7220853

Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-n

The Board of Regents of the University of Texas System Β· Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7217795

Tumor suppressor designated TS10q23.3

The Board of Regents of the University of Texas System Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7214519

Screening method for identifying heme independent modulators of soluble guanylyl cyclase (

The Board of Regents of the University of Texas System Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7211252

Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin an

The Board of Regents of the University of Texas System Β· Granted Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7204996

Method of cancer treatment

The Board of Regents of the University of Texas System Β· Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted